Disease severity in Ankylosing Spondylitis: The influence of associated inflammatory bowel disease and psoriasis

Documenti analoghi

• IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
  di: Wordsworth, P, et al.
  Pubblicazione: (2009)
• Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
  di: Orchard, T, et al.
  Pubblicazione: (1997)
• Towards defining the genetic determinants of disease severity in ankylosing spondylitis
  di: Brophy, S, et al.
  Pubblicazione: (2001)
• Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
  di: Rudwaleit, M, et al.
  Pubblicazione: (2008)
• Towards defining the genetic determinants of disease severity in ankylosing spondylitis.
  di: Brophy, S, et al.
  Pubblicazione: (2001)